FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pergolide 50microgram tablets (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Syntaris 0.025% nasal spray (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (IVAX Pharmaceuticals UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (Sandoz Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Flunisolide 25micrograms/dose nasal spray (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Syntaris 0.025% nasal spray (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypodermic U100 insulin syringe sterile single use / single patient use 0.3ml with not less than 12mm needle 0.33mm/29gauge 100 syringe VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 75 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Celance 50microgram tablets (PI) (Dowelhurst Ltd) 100 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
InSu/Light hypodermic U100 insulin syringe sterile single use / single patient use 0.3ml with 13mm needle 0.33mm/29gauge (Medicure Scientific Ltd) 100 syringe VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Syntaris 0.025% nasal spray (IVAX Pharmaceuticals UK Ltd) 24 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (PI) (Dowelhurst Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (PI) (Dowelhurst Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (IVAX Pharmaceuticals UK Ltd) 100 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (A A H Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Syntaris 0.025% nasal spray (Mawdsley-Brooks & Company Ltd) 24 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Unifine hypodermic U100 insulin syringe sterile single use / single patient use 0.3ml with 12mm needle 0.33mm/29gauge (Owen Mumford Ltd Medical Division) 10 syringe VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Flunisolide 25micrograms/actuation nasal spray (PI) (Dowelhurst Ltd) 24 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (Teva UK Ltd) 100 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Syntaris 0.025% nasal spray (Sigma Pharmaceuticals Plc) 24 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Syntaris 0.025% nasal spray (Waymade Healthcare Plc) 24 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
InSu/Light hypodermic U100 insulin syringe sterile single use / single patient use 0.3ml with 13mm needle 0.33mm/29gauge (Medicure Scientific Ltd) 10 syringe VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (PI) (Waymade Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (Sandoz Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Syntaris 0.025% nasal spray (Doncaster Pharmaceuticals Ltd) 24 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Celance 50microgram tablets (PI) (Dowelhurst Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Syntaris 0.025% nasal spray (PI) (Dowelhurst Ltd) 24 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Syntaris 0.025% nasal spray (Lexon (UK) Ltd) 24 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Flunisolide 25micrograms/dose nasal spray (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Celance 50microgram tablets (Eli Lilly & Co Ltd) 109 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (Unichem Plc) 100 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (Sigma Pharmaceuticals Plc) 100 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pergolide 50microgram tablets (Phoenix Healthcare Distribution Ltd) 100 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (medac UK) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (medac UK) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely orphenadrine 50 milligram/1 each conventional release oral tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely metronidazole 10 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metronidazole 1% cream 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Sovereign Medical) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Part VIIID Drug Tariff Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noritate 1% cream (Kestrel Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Stephar (U.K.) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Approved Prescription Services) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metronidazole 1% cream (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lysantin 50mg tablets (Imported (Denmark)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metronidazole 1% cream 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (A A H Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Unichem Plc) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Unichem Plc) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (A A H Pharmaceuticals Ltd) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (DE Pharmaceuticals) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lysantin 50mg tablets (Imported (Denmark)) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Approved Prescription Services) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Approved Prescription Services) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Waymade Healthcare Plc) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Waymade Healthcare Plc) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Doncaster Pharmaceuticals Ltd) 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (DE Pharmaceuticals) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets (Part VIIID Drug Tariff Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metronidazole 1% cream (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Sovereign Medical) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noritate 1% cream (Kestrel Healthcare Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Stephar (U.K.) Ltd) 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Sigma Pharmaceuticals Plc) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Romiplostim 250microgram powder for solution for injection vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nplate 250microgram powder for solution for injection vials (Amgen Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nplate 250microgram powder for solution for injection vials (Amgen Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nupore Plus dressing 6cm x 7cm (Sanos Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Elmiron 100mg capsules (Consilient Health Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pentosan polysulfate sodium 100mg capsules 90 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Vapour-permeable adhesive film dressing with absorbent pad 6cm x 7cm 50 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nupore Plus dressing 6cm x 7cm (Sanos Healthcare Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nupore Plus dressing 6cm x 7cm (Sanos Healthcare Ltd) 50 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Elmiron 100mg capsules (Consilient Health Ltd) 90 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Krka UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Krka UK Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Tiger Balm White ointment 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Tiger Balm Red ointment 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tiger Balm Red ointment (Omega Pharma Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tiger Balm White ointment (Omega Pharma Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Typhoid vaccine (live, oral, strain ty21a) gastro-resistant capsules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Orthovisc 30mg/2ml injection pre-filled syringes VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Arachis oil 130ml enema VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Coal tar solution 10% cream VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Squill opiate linctus paediatric VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 79 of 86 Next End

This concept is not in any reference sets

Back to Start